Third dose of the Pfizer vaccine for people who are severely immunocompromised - more details
Yesterday we announced a third dose of the Pfizer vaccine would be available for people who are severely immunocompromised. We anticipate this option will only be suitable for a very small group of the population.

Click here to read the full update

See the below information about Raukura Hauora o Tainui's Super vax saturday

Welcome to Issue #19 of the COVID-19 Vaccine Programme Update. This fortnightly newsletter for the health and disability sector contains a general programme update and clinical information for vaccinators. 

Click here to read the full update

​The Ministry has updated the advice on the timing of routine vaccines in relation to the COVID-19 vaccine. The influenza, MMR, HPV, diphtheria/tetanus/pertussis combination vaccine (Boostrix), and majority of other routine vaccines can now be administered before, after, or at the same time as the Pfizer COVID-19 vaccine, without concern for the spacing of the vaccinations.

The change supports completing a person’s recommended vaccination schedule in the shortest and most effective timeframe. The only exception to this advice is for the live-attenuated shingles vaccine (Zostavax) where a 7-day interval, before or after administering Pfizer COVID-19 vaccine, is advised.
​
This updated advice supports the uptake of the other vaccines already on the New Zealand schedule. There are no additional safety concerns associated with co-administration, over and above each vaccine’s individual safety profile. 
 
More details are available on the IMAC website https://covid.immune.org.nz/covid-19-vaccines-nz/getting-vaccinated/spacing-vaccinations